Alterations of Chk1 and Chk2 expression in colon cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Colorectal Disease

• Publication date

  2008-08-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00384-008-0551-8PMID 18679694
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma.

  2006cited by this paper
• Treatment options in metastatic renal carcinoma: an embarrassment of riches.

  2006cited by this paper
• Increased risk of breast cancer associated with CHEK2*1100delC.

  2006cited by this paper
• Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

  2006cited by this paper
• DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

  2005influential reference
• The Chk2 protein kinase.

  2004influential reference
• CHEK2 is a multiorgan cancer susceptibility gene.

  2004cited by this paper
• Chk1 in the DNA damage response: conserved roles from yeasts to mammals.

  2004cited by this paper
• chk-1 is an Essential Gene and is Required for an S-M Checkpoint During Early Embryogenesis

  2004cited by this paper
• DNA damage tumor suppressor genes and genomic instability.

  2004influential reference
• Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex.

  2004cited by this paper
• Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time.

  2004influential reference
• Chk2 activates E2F-1 in response to DNA damage

  2003cited by this paper
• CHEK2 1100delC and colorectal cancer

  2003cited by this paper
• Determination of substrate specificity and putative substrates of Chk2 kinase.

  2003cited by this paper
• Analysis of CHK2 in vulval neoplasia

  2002cited by this paper
• Hus1 acts upstream of chk1 in a mammalian DNA damage response pathway.

  2002cited by this paper
• Concomitant inactivation of p53 and Chk2 in breast cancer

  2002cited by this paper
• A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

  2002cited by this paper
• A unified view of the DNA-damage checkpoint.

  2002cited by this paper
• Chk2 Activation and Phosphorylation-Dependent Oligomerization

  2002cited by this paper
• Increased expression of CHK2 in human gastric carcinomas harboring p53 mutations

  2002influential reference
• CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.

  2002cited by this paper
• Characterization of Tumor-associated Chk2 Mutations*

  2001cited by this paper
• Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer.

  2001cited by this paper
• DNA damage: Chk1 and Cdc25, more than meets the eye.

  2001cited by this paper
• DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology.

  2001cited by this paper
• Chk2 kinase — a busy messenger

  2001cited by this paper
• Initial Steps of Ferulic Acid Polymerization by Lignin Peroxidase*

  2001cited by this paper
• Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability.

  2001cited by this paper
• Pathways governing G1/S transition and their response to DNA damage

  2001influential reference
• The hCds1 (Chk2)-FHA Domain Is Essential for a Chain of Phosphorylation Events on hCds1 That Is Induced by Ionizing Radiation*

  2001cited by this paper
• Mammalian G1- and S-phase checkpoints in response to DNA damage.

  2001influential reference
• Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours

  2001cited by this paper
• Threonine 68 of Chk2 Is Phosphorylated at Sites of DNA Strand Breaks*

  2001cited by this paper
• p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.

  2001cited by this paper
• The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

  2000cited by this paper
• Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems.

  2000cited by this paper
• Analysis of the candidate target genes for mutation in microsatellite instability-positive cancers of the colorectum, stomach, and endometrium.

  2000cited by this paper
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers

  1999cited by this paper
• CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers.

  1999cited by this paper
• NMR Solution Structure of Domain 1 of Human Annexin I Shows an Autonomous Folding Unit*

  1999cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Identification of tissue-specific nuclear antigens transferred to nitrocellulose from polyacrylamide gels.

  1981cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979influential reference
• Determination of protein by a modified Lowry procedure in the presence of some commonly used detergents.

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970influential reference

• Checkpoint kinase 1 in colorectal cancer: Upregulation of expression and promotion of cell proliferation

  2025cites this paper
• Exploring the therapeutic potential of Premna barbata Wall. ex Schauer stem bark in colon cancer: apoptosis induction, cell cycle analysis, and in-silico insights

  2025cites this paper
• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• Activation of the DNA damage response pathway in the infected gastric tissue with Helicobacter pylori: a case-control study.

  2023cites this paper
• Guarding against digestive-system cancers: Unveiling the role of Chk2 as a potential therapeutic target

  2023cites this paper
• The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study

  2023cites this paper
• Nanoparticle-Mediated PRDX2 Inhibition for Specific Targeting of CHK2-Null Colorectal Cancer.

  2022cites this paper
• Induction of Mitosis Delay and Apoptosis by CDDO-TFEA in Glioblastoma Multiforme

  2021cites this paper
• RTA404, an Activator of Nrf2, Activates the Checkpoint Kinases and Induces Apoptosis through Intrinsic Apoptotic Pathway in Malignant Glioma

  2021cites this paper
• Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities Perspective

  2021cites this paper
• The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

  2020cites this paper
• Predictive and Prognostic Value of DNA Damage Response Associated Kinases in Solid Tumors

  2020influential citation
• FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2

  2020cites this paper
• Cell-type-specific role of CHK2 in mediating DNA damage-induced G2 cell cycle arrest

  2020cites this paper
• Identification of biomarkers in colon cancer based on bioinformatic analysis

  2020cites this paper
• Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights.

  2019cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro

  2018cites this paper
• Cytotoxic effect of helichrysetin on cancer cell lines and its mechanisms / Ho Yen Fong

  2017cites this paper
• Cancer TARGETases: DSB repair as a pharmacological target.

  2016cites this paper
• Biomarkers for Early Detection of Familial Breast Cancer

  2015cites this paper
• Experimental colitis in mice is attenuated by topical administration of chlorogenic acid

  2015cites this paper
• CHK2 Immunohistochemical Expression in Colon Cancer and its Relation with Clinicopathological Features and Outcome in Metastatic ColonCancer Patients

  2014cites this paper
• Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors.

  2014cites this paper
• Localisation et fonction de CHK2 en mitose

  2013cites this paper
• DNA repair mechanisms in colorectal carcinogenesis.

  2012cites this paper
• Papel de DUSP1 en progresión tumoral y en respuesta a CDDP en cáncer no microcítico de pulmón

  2011cites this paper
• Checkpoint kinase 1 modulates sensitivity to cisplatin after spindle checkpoint activation in SW620 cells.

  2010cites this paper
• Importance of DNA damage checkpoints in the pathogenesis of human cancers.

  2010cites this paper
• The High Throughput Screening of Direct Regulatory microRNA and Their Target Genes*: The High Throughput Screening of Direct Regulatory microRNA and Their Target Genes*

  2010cites this paper
• DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.

  2009cites this paper
• Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.

  2009cites this paper
• Role of CHK2 in cancer development

  2008cites this paper
• World Journal of Clinical Oncology

  year unknowncites this paper
• RESEARCH ARTICLE Identification and Validation of Prognostic Biomarker Signatures Associated with Overall Survival in Colorectal Cancer: Evidence from Bioinformatics Analysis and an in vivo Study

  year unknowncites this paper